|

Mid-day market update: Dow falls over 100 points, Silicon Laboratories shares spike higher

Midway through trading Wednesday, the Dow traded down 0.30% to 35,648.39 while the NASDAQ rose 0.32% to 15,283.97. The S&P also fell, dropping 0.03% to 4,573.51.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 46,497,710 cases with around 759,930 deaths. India confirmed a total of at least 34,215,650 cases and 455,680 deaths, while Brazil reported over 21,748,980 COVID-19 cases with 606,290 deaths. In total, there were at least 245,403,800 cases of COVID-19 worldwide with more than 4,981,390 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Communication services shares gained by 0.8% on Wednesday. Meanwhile, top gainers in the sector included Qutoutiao Inc. QTT +1.9% (Get Free Alerts for QTT), up 6% and Stagwell Inc. STGW +5.64% (Get Free Alerts for STGW) up 5%.

In trading on Wednesday, energy shares fell 1.5%.

Top Headline

The Coca-Cola Company KO +1.97% reported better-than-expected results for its third quarter.

Coca-Cola reported quarterly adjusted earnings of $0.65 per share, exceeding analysts’ estimates of $0.58 per share. The company’s sales came in at $10.00 billion, versus expectations of $9.75 billion.

Equities Trading UP

AgriFORCE Growing Systems, Ltd. AGRI +141.67% shares shot up 143% to $5.25. AgriFORCE Growing Systems reported binding LOI to acquire a European
agriculture/horticulture and AgTech consulting firm for $29 million.

Shares of Enphase Energy, Inc. ENPH +27.51% got a boost, shooting 21% to $210.64 after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.

Silicon Laboratories Inc. SLAB +17.2% shares were also up, gaining 15% to $178.13 after the company reported better-than-expected Q3 results and issued Q4 adjusted EPS guidance above estimates.

Equities Trading DOWN

Cortexyme, Inc. CRTX -75.07% shares tumbled 74% to $14.96 after the company shared an update. Cortexyme reported Phase 2/3 GAIN trial data for its Alzheimer’s disease trial. The company stated co-primary endpoints were not met for ADAS-Cog11 and ADCS-ADL in the overall population. Subgroups saw a 50% slowing level for infection for ADAS-Cog11.

Shares of Angion Biomedica Corp. ANGN -54.09% were down 54% to $4.0050. After flopping a test in COVID-19 earlier this year, Angion Biomedica’s lead candidate drug has hit a setback again, this time in kidney transplant patients. Angion and partner Vifor Pharma's ANG-3777 failed to beat placebo in terms of improving eGFR, a measure of kidney function, in patients who received a deceased donor kidney transplant and were at high risk of developing delayed graft function.

DBV Technologies S.A. DBVT -25.75% was down, falling 28% to $3.64 after the company reported a loss for the third quarter.

Commodities

In commodity news, oil traded down 1.7% to $83.24, while gold traded down 0.1% to $1,792.90.

Silver traded up 0.3% Wednesday to $24.165 while copper fell 2% to $4.3975.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 0.42%, the Spanish Ibex Index fell 0.35% and the German DAX 30 declined 0.36%. Meanwhile, the London’s FTSE 100 fell 0.29%, French CAC 40 fell 0.23% and Italy’s FTSE MIB declined 0.71%.

Loans to households in the Eurozone climbed 4.1% year-over-year in September. Industrial producer prices in the France’s domestic market rose 1.7% from a month ago in September, while consumer confidence declined to 99 in October from a revised level of 101 in September.

Import prices in Germany rose 17.7% year-over-year in September, while GfK consumer climate indicator rose to 0.9 heading into November.

Economics

US durable goods orders fell 0.4% for September.

The US goods trade deficit widened to $96.25 billion in September.

US wholesale inventories increased 1.1% to $739.5 billion for September.

US crude oil inventories climbed 4.267 million barrels in the week ending October 22, following a 0.431 million drop in the prior period, the Energy Information Administration said.

The Treasury is set to auction 5-year notes at 1:00 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD flirts with daily highs, retargets 1.1900

EUR/USD regains upside traction, returning to the 1.1880 zone and refocusing its attention to the key 1.1900 barrier. The pair’s slight gains comes against the backdrop of a humble decline in the US Dollar as investors continue to assess the latest US CPI readings and the potential Fed’s rate path.

GBP/USD remains well bid around 1.3650

GBP/USD maintains its upside momentum in place, hovering around daily highs near 1.3650 and setting aside part of the recent three-day drop. Cable’s improved sentiment comes on the back of the Greenback’s  irresolute price action, while recent hawkish comments from the BoE’s Pill also collaborate with the uptick.

Gold clings to gains just above $5,000/oz

Gold is reclaiming part of the ground lost on Wednesday’s marked decline, as bargain-hunters keep piling up and lifting prices past the key $5,000 per troy ounce. The precious metal’s move higher is also underpinned by the slight pullback in the US Dollar and declining US Treasury yields across the curve.

Crypto Today: Bitcoin, Ethereum, XRP in choppy price action, weighed down by falling institutional interest 

Bitcoin's upside remains largely constrained amid weak technicals and declining institutional interest. Ethereum trades sideways above $1,900 support with the upside capped below $2,000 amid ETF outflows.

Week ahead – Data blitz, Fed Minutes and RBNZ decision in the spotlight

US GDP and PCE inflation are main highlights, plus the Fed minutes. UK and Japan have busy calendars too with focus on CPI. Flash PMIs for February will also be doing the rounds. RBNZ meets, is unlikely to follow RBA’s hawkish path.

Ripple Price Forecast: XRP potential bottom could be in sight

Ripple edges up above the intraday low of $1.35 at the time of writing on Friday amid mixed price actions across the crypto market. The remittance token failed to hold support at $1.40 the previous day, reflecting risk-off sentiment amid a decline in retail and institutional sentiment.